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Abstract
Background:  Several  locoregional  techniques  have  been  described  for  the  management  of  acute
and chronic  pain  after  breast  surgery.  The  optimal  technique  should  be  easy  to  perform,  repro-
ducible, with  little  discomfort  to  the  patient,  little  complications,  allowing  good  control  of
acute pain  and  a  decreased  incidence  of  chronic  pain,  namely  intercostobrachial  neuralgia  for
being the  most  frequent  entity.
Objectives:  The  aim  of  this  study  was  to  evaluate  the  paravertebral  block  with  preoperative
single needle  prick  for  major  breast  surgery  and  assess  initially  the  control  of  postoperative
nausea and  vomiting  (PONV)  and  acute  pain  in  the  ﬁrst  24  h  and  secondly  the  incidence  of
neuropathic  pain  in  the  intercostobrachial  nerve  region  six  months  after  surgery.
Methods: The  study  included  80  female  patients,  ASA  I-II,  aged  18--70  years,  undergoing  major
breast surgery,  under  general  anesthesia,  stratiﬁed  into  2  groups:  general  anesthesia  (inhalation
anesthesia  with  opioids,  according  to  hemodynamic  response)  and  paravertebral  (paravertebral
block with  single  needle  prick  in  T4  with  0.5%  ropivacaine  +  adrenaline  3  g  mL−1 with  a  volume
of 0.3  mL  kg−1 preoperatively  and  subsequent  induction  and  maintenance  with  general  inhala-
arly  postoperative  period,  patient-controlled  analgesia  (PCA)  was
or  bolus  on  demand  for  24  h.  Intraoperative  fentanyl,  postoperative
chnique-related  complications,  pain  at  rest  and  during  movementtional anesthesia).  In  the  e
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were  recorded  at  0  h,  1  h,  6  h  and  24  h,  as  well  as  episodes  of  PONV.  All  variables  identiﬁed
as factors  contributing  to  pain  chronicity  age,  type  of  surgery,  anxiety  according  to  the  Hos-
pital Anxiety  and  Depression  Scale  (HADS),  preoperative  pain,  monitoring  at  home;  body  mass
index (BMI)  and  adjuvant  chemotherapy/radiation  therapy  were  analyzed,  checking  the  homo-
geneity of  the  samples.  Six  months  after  surgery,  the  incidence  of  neuropathic  pain  in  the
intercostobrachial  nerve  was  assessed  using  the  DN4  scale.
Results:  The  Visual  Analog  Scale  (VAS)  values  of  paravertebral  group  at  rest  were  lower  through-
out the  24  h  of  study  0  h  1.90  (±2.59)  versus  0.88  (±1.5)  1  h  2.23  (±2.2)  versus  1.53  (±1.8)  6  h
1.15 (±1.3)  versus  0.35  (±0.8);  24  h  0.55  (±0.9)  versus  0.25  (±0.8)  with  statistical  signiﬁcance
at 0  h  and  6  h.  Regarding  movement,  paravertebral  group  had  VAS  values  lower  and  statistically
signiﬁcant  in  all  four  time  points:  0  h  2.95  (±3.1)  versus  1.55  (±2.1);  1  h  3.90  (±2.7)  versus  2.43
(±1.9) 6  h  2.75  (±2.2)  versus  1.68  (±1.5);  24  h  2.43  (±2.4)  versus  1.00  (±1.4).  The  paravertebral
group consumed  less  postoperative  fentanyl  (2.38  ±  0.81  g  kg−1 versus  3.51  ±  0.81  g  kg−1)  and
morphine  (3.5  mg  ±  3.4  versus  7  mg  ±  6.4)  with  statistically  signiﬁcant  difference.  Chronic  pain
evaluation  of  at  6  months  of  paravertebral  group  found  fewer  cases  of  neuropathic  pain  in  the
intercostobrachial  nerve  region  (3  cases  versus  7  cases),  although  not  statistically  signiﬁcant.
Conclusions:  Single-injection  paravertebral  block  allows  proper  control  of  acute  pain  with  less
intraoperative  and  postoperative  consumption  of  opioids  but  apparently  it  cannot  prevent  pain
chronicity.  Further  studies  are  needed  to  clarify  the  role  of  paravertebral  block  in  pain  chronicity
in major  breast  surgery.
©  2015  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Bloqueio  paravertebral  no  controle  da  dor  aguda  pós-operatória  e  dor  neuropática
do  nervo  intercostobraquial  em  cirurgia  mamária  de  grande  porte
Resumo
Justiﬁcativa:  Estão  descritas  várias  técnicas  locorregionais  para  a  abordagem  da  dor  aguda  e
dor crônica  após  cirurgia  de  mama.  O  ideal  seria  uma  técnica  fácil  de  fazer,  reprodutível,  com
pouco desconforto  para  as  doentes,  com  poucas  complicac¸ões  e  que  permitirá  um  bom  controle
da dor  aguda  e  uma  diminuic¸ão  da  incidência  de  dor  crônica,  notadamente  dor  neuropática  do
intercostobraquial,  por  ser  a  entidade  mais  frequente.
Objetivos:  Estudar  a  aplicac¸ão  de  bloqueio  paravertebral  com  picada  única  no  pré-operatório
de cirurgia  mamária  de  grande  porte.  Avaliar  numa  primeira  fase  o  controle  de  dor  aguda
e náuseas-vômitos  no  pós-operatório  (NVPO)  nas  primeiras  24  horas  e  numa  segunda  fase  a
incidência  de  dor  neuropática  na  região  do  nervo  intercostobraquial  seis  meses  após  a  cirurgia.
Métodos: Foram  incluídas  80  doentes  do  sexo  feminino,  ASA  I-II,  entre  18  e  70  anos,  submetidas
a cirurgia  mamária  de  grande  porte  sob  anestesia  geral,  estratiﬁcadas  em  dois  grupos:  anestesia
geral (anestesia  geral  inalatória  com  opioides  segundo  resposta  hemodinâmica)  e  paravertebral
(bloqueio paravertebral  com  picada  única  em  T4  com  ropivacaína  0,5%  +  adrenalina  3  g/mL
com um  volume  de  0,3  mL/kg  pré-operatoriamente  e  posterior  induc¸ão  e  manutenc¸ão  com
anestesia  geral  inalatória).  No  pós-operatório  imediato  foi  colocada  PCA  (Patient-controlled
analgesia) de  morﬁna  programada  com  bolus  a  demanda  durante  24  horas.  Foram  registados
fentanil intraoperatório,  consumo  de  morﬁna  pós-operatória,  complicac¸ões  relacionadas  com  as
técnicas, dor  em  repouso  e  ao  movimento  a  0,  1  h,  6  h  e  24  h,  assim  como  os  episódios  de  NVPO.
Foram analisadas  todas  as  variáveis  identiﬁcadas  como  fatores  de  croniﬁcac¸ão  da  dor  idade,
tipo de  cirurgia,  ansiedade  segundo  escala  de  HADS  (Hospital  Anxiety  and  Depression  scale),
dor pré-operatória;  acompanhamento  no  domicílio;  índice  de  massa  corporal  (IMC),  tratamentos
adjuvantes  de  quimioterapia/radioterapia  e  foi  veriﬁcada  a  homogeneidade  das  amostras.  Aos
seis meses  da  cirurgia  foi  avaliada,  segundo  escala  DN4,  a  incidência  de  dor  neuropática  na  área
do nervo  intercostobraquial.
Resultados:  O  grupo  paravertebral  teve  valores  de  VAS  (Escala  Visual  Analógica)  em  repouso
mais baixos  ao  longo  das  24  horas  de  estudo  0  h  1,90  (±  2,59)  versus  0,88  (±  1,5);  1  h  2,23  (±  2,2)
versus 1,53  (±  1,8);  6  h  1,15  (±  1,3)  versus  0,35  (±  0,8);  24  h  0,55  (±  0,9)  versus  0,25  (±  0,8)  com
signiﬁcado  estatístico  às  0  e  às  6  horas.  Em  relac¸ão  ao  movimento  o  grupo  paravertebral  teve
valores de  VAS  mais  baixos  e  com  signiﬁcância  estatística  nos  quatro  momentos  de  avaliac¸ão:  0  h
2,95 (±  3,1)  versus  1,55  (±  2,1);  1  h  3,90  (±  2,7)  versus  2,43  (±  1,9)  6  h  2,75  (±  2,2)  versus  1,68
(± 1,5);  24  h  2,43  (±  2,4)  versus  1,00  (±  1,4).  O  grupo  paravertebral  consumiu  menos  fentanil
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(2,38  ±  0,81  g/Kg  versus  3,51  ±  0,81  g/Kg)  e  menos  morﬁna  no  pós-operatório  (3,5  mg  ±  3,4
versus 7  mg  ±  6,4),  com  diferenc¸a  estatisticamente  signiﬁcativa.  Na  avaliac¸ão  de  dor
crônica aos  seis  meses  no  grupo  paravertebral  houve  menos  casos  de  dor  neuropática  na
região do  nervo  intercostobraquial  (três  versus  sete)  embora  sem  signiﬁcância  estatística.
Conclusões:  O  bloqueio  paravertebral  com  picada  única  permite  um  adequado  controlr  da  dor
aguda com  menor  consumo  de  opioides  intraopreatórios  e  pós-operatórios,  mas  aparentemente
não consegue  evitar  a  croniﬁcac¸ão  da  dor.  Mais  estudos  são  necessários  para  esclarecer  o  papel
do bloqueio  paravertebral  na  croniﬁcac¸ão  da  dor  em  cirurgia  mamária  de  grande  porte.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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bined  with  paravertebral  block)  and  general  anesthesiaIntroduction
In  recent  years  breast  cancer  the  most  frequent  cancer  in
women1 has  decreased  its  mortality,  but  unfortunately  often
associated  with  increased  morbidity  due  to  sequelae  of  the
treatment  used.2
Breast  cancer  surgery  has  many  risk  factors  for  post-
operative  nausea  and  vomiting  (PONV),  reaching  up  to
70%  in  some  series.  In  0.2%  of  cases,  it  corresponds  to
uncontrollable  cases  that  delay  hospital  discharge,  require
unexpected  admissions,  lower  rates  of  patient  satisfaction,
and  increased  hospital  costs.3,4
Chronically,  half  of  patients  undergoing  breast  surgery
had  some  kind  of  surgery-related  pain,5,6 either  nocicep-
tive  or  neuropathic.  Pain  in  the  intercostobrachial  nerve
area  is  the  most  common  neuropathic  pain.7 Among  the
factors  that  may  inﬂuence  chronic  pain,  the  most  readily
modiﬁable  are  postoperative  pain  and  opioid  consumption,
so  that  the  greater  the  intensity  of  postoperative  pain
and  analgesic  consumption,  the  higher  the  risk  of  chronic
pain.8
Paravertebral  block  seems  to  produce  an  effective  block
of  the  painful  pathways,  characterized  by  unilateral  regional
blockade  of  several  dermatomes.  It  also  allows  a  sympa-
thetic  block  that  could  have  some  beneﬁt  in  oncology.9
Currently,  there  are  ongoing  studies  aimed  at  identifying
if  there  is  a  relationship  between  the  loco-regional  tech-
nique  and  tumor  recurrence,  particularly  in  the  breast
area.10
The  usefulness  of  this  technique  for  effective  postop-
erative  pain  management  has  already  been  evaluated  in
different  studies,11,12 although  there  are  still  some  doubts
about  the  paravertebral  space  approach,  more  effective  and
with  fewer  side  effects.  There  are  reports  of  single-  and
multiple-injection  techniques  with  or  without  a  catheter
placement  are  described.13,14
This  study  was  designed  in  two  stages  in  order  to  com-
pare  two  different  approaches  in  breast  surgery  anesthesia:
a  paravertebral  block  with  single-injection  associated  with
general  anesthesia  versus  general  anesthesia  alone.  At
the  ﬁrst  stage  we  intended  to  evaluate  the  acute  pain
management  in  the  immediate  postoperative  period  and
occurrence  of  PONV  in  patients  undergoing  major  surgery
for  breast  cancer.  At  the  second  stage  we  evaluated  the
g
cresence  of  neuropathic  pain  in  the  intercostobrachial
egion  in  the  same  group  of  patients  six  months  after  the
urgery.
aterial and methods
 prospective,  stratiﬁed  observational  study  was  designed.  It
as  assumed  a  difference  of  2.64  in  the  average  assessment
f  the  Visual  Analog  Scale  (VAS)  at  24  h  between  the  patients
ho  underwent  paravertebral  block  and  general  anesthesia
nd  patients  who  underwent  general  anesthesia  alone,  with
0%  study  power,  5%  signiﬁcance  level,  and  sample  stratiﬁca-
ion  according  to  the  anxiety,  age  group,  and  type  of  surgery
ariables,  and  we  estimated  the  inclusion  of  80  patients  --
0  in  each  group.  The  sample  stratiﬁcation  variables  were
hosen  for  being  the  most  often  cited  factors  as  independent
ariables  for  the  development  of  acute  pain  and/or  chronic
ain.
Anxiety  was  assessed  using  the  Hospital  Anxiety  and
epression  scale  (HADS).  HADS  is  a  hospital  tool  widely
sed  for  screening  situations  of  anxiety  and  depression  in
ospitalized  cancer  patients.15 It  consists  of  14  questions
odd-numbered  questions  assess  anxiety  the  even-numbered
ssess  depression)  with  responses  scored  on  a  scale  of  0--3.
otal  score  is  obtained  by  summing  the  values  of  each  sub-
cale.  In  both  cases  the  higher  the  score,  the  higher  the
evel  of  anxiety  or  depression.  This  scale  was  completed  by
atients  in  the  pre-anesthetic  visit  before  surgery.  For  this
tudy  we  used  a cut-off  >8  points.
Inclusion  and  exclusion  criteria  are  shown  in  Table  1.  The
tudy  was  performed  between  January  2012  and  January
013.  It  was  approved  by  the  Ethics  Committee  of  the  insti-
ution  and  all  patients  gave  their  written  informed  consent
o  participate  in  the  study.
irst phase of the study
reoperatively,  all  patients  were  stratiﬁed  into  two
roups  according  to  the  type  of  surgery,  HADS  score,
nd  age:  paravertebral  group  (general  anesthesia  com-roup.
Before  the  induction  of  anesthesia,  peripheral  route
atheterization  was  performed,  and  patients  were
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Table  1  Inclusion  and  exclusion  criteria  of  the  study.
Inclusion  criteria
Female
Age  between  18  and  70  years
Breast  cancer,  undergoing  major  resection  (lumpectomy
with axillary  dissection,  MRM,  and  mastectomy
with/without  axillary  dissection)
ASA  I-II
Informed  consent  to  participate  in  the  study
Exclusion  criteria
Allergy  to  nonsteroidal  anti-inﬂammatory  drugs  (NSAIDs);
local  anesthetics;  propofol;  opioids;  paracetamol;
antiemetic
Patients  on  chronic  treatment  with  antibiotics
Obesity  (BMI  >  30)
Bilateral  or  multiple  surgical  procedure
Contraindication  to  paravertebral  block  (including
coagulation  disorders/anatomical  changes)
Severe  respiratory  disease
Pregnancy
Inability  to  normal  understanding  of  the  Visual  Analog
Scale (VAS)
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Table  2  Preventive  protocol  of  PONV  used  in  the  study.
Institutional  preventive  protocol  of  postoperative  nausea
and  vomiting
2  risk  factors  or  a  history  of  PONV:  prophylaxis  with  one
drug (Droperidol);
3  risk  factors  or  history  of  NVPO  +  1  risk  factor:
prophylaxis  with  2  drugs  (Droperidol  +  Ondansetrom);
Previous  history  of  PONV  more  than  once  +  another  risk
factor:  Prophylaxis  with  3  drugs  (Dexamethasone,
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ponitored  according  to  ASA  standards  and  bispectral
ndex  (BIS)  anesthetic  depth.
aravertebral  group
aravertebral  block  was  performed  with  single-injection,
ccording  to  the  classic  technique,16 at  the  T4  level
ith  Tuohy  needle  18G,  with  0.5%  ropivacaine  +  adrenaline
 g  mL−1,  with  a  volume  of  0.3  mL  kg−1 (maximum  total  vol-
me  of  30  mL).  Subsequently,  anesthesia  was  induced  with
ropofol  (1.5  mg  kg−1 h−1)  and  fentanyl  (2  g  kg−1)  and  laryn-
eal  mask  airway  (LMA)  was  inserted.
eneral  anesthesia  group
nesthesia  was  induced  with  propofol  (1.5  mg  kg−1 h−1)  and
entanyl  (2  g  kg−1)  and  LMA  was  inserted.  The  maintenance
f  anesthesia  was  performed  in  both  groups  with  desﬂu-
ane  to  maintain  BIS  values  at  45--60  with  a  mixture  of
2/air.
Both  groups  received  parecoxib  40  mg  IV  before  the  start
f  surgery.  During  maintenance,  fentanyl  (1.5  g  kg−1)  was
dministered  if  there  was  an  increase  of  20%  from  base-
ine  values  of  mean  arterial  pressure  (MAP)  and  heart  rate
HR).
For  maintenance  of  hemodynamic  stability,  ephedrine
r  atropine  was  administered,  at  the  anesthesiologist’s
iscretion,  if  veriﬁed  a  decreased  in  MAP  >  20%  or
R  <  50  beats/min  of  baseline  values.
In  all  patients,  the  institutional  protocol  for  the  preven-
ion  of  nausea  and  vomiting  was  administered,  according  to
he  predictive  model  by  Apfel  and  colleagues,  with  three
ntiemetic  intervention  lines  (Table  2).
b
w
(
gDroperidol,  Ondansetron).
At  the  end  of  surgery,  patient-controlled  analgesia  (PCA)
ith  morphine  was  initiated,  programmed  with  bolus  of
 mg  on  demand  and  5  min  lock-out  and  a maximum  dose
f  6  mg  h−1 during  the  ﬁrst  24  h  postoperatively.
In  the  different  phases  of  the  study  (preoperative,  intra-
perative,  postoperative),  we  recorded  different  variables
hat  were  considered  relevant  in  the  development  of  acute
nd/or  chronic  pain  or  that  could  interfere  with  the  study
esults.  These  variables  are  shown  in  Table  3.
We  assessed  pain  at  rest  according  to  the  VAS  score
0--10),  as  well  as  pain  with  mobilization  of  the  ipsilateral
rm  interpreted  as  90◦ arm  abduction  at  four  different  times
fter  surgery:  0  h;  1  h;  6  h  and  24  h  after  surgery.
We  evaluated  the  occurrence  of  PONV  using  a  cate-
orical  scale  of  the  institution  (0  =  no  nausea;  1  =  motion
ickness;  2  =  nausea  at  rest;  3  =  vomiting;  4  =  vomiting
espite  antiemetics)  and  the  need  for  antiemetic  rescue
edication,  in  the  ﬁrst  24  h.
tatistical  analysis
 descriptive  analysis  of  all  variables  was  performed  and
iven  the  absolute  and  relative  frequencies  for  categorical
ariables  and  mean  and  standard  deviation  or  median  and
nterquartile  range  for  continuous  variables,  according  to
he  adequacy  for  each  variable.
Continuous  variables  were  compared  using  the  inde-
endent  sample  t-test  and  categorical  variables  using  the
hi-square  test.  If  there  were  no  statistical  assumptions  for
heir  application,  we  used  the  optional  statistical  tests:
ann--Whitney  and  Fisher,  respectively.  The  analysis  was
erformed  with  a  signiﬁcance  level  of  0.05.
irst  phase  results
e  checked  the  homogeneity  of  the  two  groups  and  there
ere  no  statistically  signiﬁcant  differences  in  variables,  such
s  age,  type  of  surgery,  and  HADS.  The  groups  proved  to  be
omogeneous  in  the  analysis  of  other  variables  that  char-
cterize  the  sample,  such  as  the  duration  of  surgery;  and
ariables  related  to  the  onset  of  chronic  pain,  such  as  the
resence  of  breast  pain  before  surgery,  body  mass  index
ody  (BMI),  and  family  support  (Table  4).During  surgery,  the  average  consumption  of  fentanyl
as  signiﬁcantly  lower  (p  <  0.01)  in  the  paravertebral  group
2.38  ±  0.81  g  kg−1)  compared  with  the  general  anesthesia
roup  (3.51  ±  0.81  g  kg−1) (Table  5).
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Table  3  Parameters  recorded  in  the  preoperative,  intraoperative,  and  postoperative  periods.
Preoperative  Intraoperative  Postoperative  Six  months  after  surgery
HADS  Fentanyl
Age  Ephedrine -  VAS  at  rest
(0 h--1  h--6  h--24  h)
Presence  of  neuropathic  pain
in  the  intercostobrachial
nerve  region
Type of  surgery  Atropine
BMI  Complications: -  VAS  on  movement
(0 h--1  h--6  h--24  h)Family support -  Hypotension:  >  20%
baseline
-  DN4
- PONV  (0  h-1  h-6  h-24  h)
Presence of  breast  pain  -  Bradycardia  <  50  bpm;
Pleural  puncture;
-  EORTC-QLQ  C30
- Morphine -  EORTC-QLQ-BR23
- Pneumothorax
-  Local  hematoma;
- Local  bleeding;
- Convulsions;
-  Allergic  reaction.
Table  4  Variables  related  to  acute  and  chronic  pain  in  the  study  ﬁrst  phase.
Variable Paravertebral  group  (n  =  40) General  anesthesia  group  (n  =  40) p
Age  55.10  (±9.8)  52.68  (±8.9)  0.2
HADS (%)  0.82
HADS ≤  8  51.3  48.7
HADS >  8  46.7  52.3
Type of  surgery  (%)  0.85
TA +  lymphadenectomy  54.5  45.5
Simple mastectomy 50  50
MRM 46.4  53.6
BMI (%)  25.6  (±3.4)  25.21  (±3.5)  0.6
Duration of  surgery  (min)  86.9  (±26.9)  84.75  (±28.6)  0.7
Preoperative pain  (%)  33.3  66.7  0.31
Family support  (%)  53.6  46.4  0.056
Table  5  VAS  score  at  rest  and  on  movement;  fentanyl  and  morphine  consumption.
General  anesthesia  (mean)  Paravertebral  +  GA  (mean)  p
VAS  at  rest
0  h  1.90  (±2.59)  0.88  (±1.5)  0.027
1 h  2.23  (±2.2)  1.53  (±1.8)  0.124
6 h  1.15  (±1.3)  0.35  (±0.8)  0.002
24 h  0.55  (±0.9)  0.25  (±0.8)  0.128
VAS on  movement
0 h  2.95  (±3.1)  1.55  (±2.1)  0.018
1 h  3.90  (±2.7)  2.43  (±1.9)  0.006
6 h  2.75  (±2.2)  1.68  (±1.5)  0.011
24 h  2.43  (±2.4)  1.00  (±1.4)  0.002
Fentanil (g/Kg) 3.51  (±0.81)  2.38  (±0.81)  <0.01
Morphine (mg) 7  (±6.4) 3.5  (±3.4)  0.002
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Table  6  Postoperative  episodes  of  nausea  and  vomiting.
PONV  General  anesthesia  Paravertebral  +  GA  p
0  h  1  1  0.6
1 h  3  1  0.5
6 h  2  2  0.6
24 h  0  0  0.3
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There  were  no  signiﬁcant  differences  for  other  variables
that,  according  to  the  literature,  may  increase  the  likeli-
hood  of  eventually  developing  chronic  pain,  such  as  type
of  surgery,  anxiety,  previous  breast  pain  or  adjuvant  treat-When  the  mean  values  of  VAS  at  rest  were  compared
etween  the  anesthesia  groups  at  the  several  times  mea-
ured,  it  appears  to  be  always  higher  in  the  general
nesthesia  group.  Only  at  times  0  h  and  6  h,  the  differences
n  mean  VAS  were  signiﬁcant.  So,  one  can  say  that  mean  VAS
t  rest  at  0  h  and  6  h  is  signiﬁcantly  higher  in  the  general
nesthesia  group  (Table  5).
Regarding  VAS  evaluated  during  movement,  which
nvolves  a  90◦ abduction  of  the  limb  ipsilateral  to  surgery,  at
ll  time-points,  the  general  anesthesia  group  had  mean  val-
es  higher  than  those  recorded  for  the  paravertebral  group
ith  statistical  signiﬁcance  (Table  5).
The  group  general  anesthesia  had  a  higher  num-
er  of  patients  (14;  35%)  with  severe  pain  (VAS  at
est  ≥  7)  over  24  h  compared  with  the  paravertebral
roup  (6;  6%).  However,  this  difference  is  not  signiﬁcant
p  = 0.069).
Compared  to  postoperative  morphine  consumption,  there
as  a  higher  proportion  of  patients  in  the  general  anesthesia
roup:  80%  of  patients  in  contrast  to  67.5%  of  the  paraver-
ebral  group,  although  there  was  no  statistically  signiﬁcant
ifferences  (p  =  0.3).
Of  the  patients  who  consumed  morphine,  the  general
nesthesia  group  consumed  more  than  twice  the  paraver-
ebral  group,  with  an  average  of  7  mg  (±6.4)  in  general
nesthesia  group  and  3.5  mg  (±3.4)  in  paravertebral  group,
 difference  statistically  signiﬁcant  (p  =  0.002).
Regarding  nausea  and  vomiting  there  were  few  events
n  each  subtype  according  to  the  institution’s  scale,  so
he  results  are  presented  as  the  sum  of  any  episode
f  nausea  and/or  vomiting  24  h  after  surgery.  We  found
hat  the  general  anesthesia  group  had  more  episodes
f  NVPO,  with  six  cases  (15%),  compared  to  four  cases
10.3%)  recorded  for  the  paravertebral  group.  There  were
o  statistically  signiﬁcant  differences  between  groups
Table  6).
There  were  no  serious  complications  related  to  the
echnique  throughout  the  study.  There  was  a  greater  num-
er  of  intraoperative  hypotension  in  the  paravertebral
roup  (9  versus  3  cases),  with  statistically  signiﬁcant  dif-
erence  (p  =  0.007)  and  need  for  ephedrine  administration
n  22.5%  of  patients  in  paravertebral  group  and  2.5%  in
he  general  anesthesia  group;  ﬁve  cases  had  bradycar-
ia  (HR  <  50)  in  both  groups,  with  12.5%  of  patients  in
aravertebral  group  and  7.5%  in  the  general  anesthesia
roup  requiring  atropine  administration.  There  was  one
ase  of  pleural  puncture  in  the  paravertebral  group  without
neumothorax  signs  postoperatively.  There  were  no  occur-
ences  of  local  hematoma,  bleeding,  convulsions  and  allergic
eactions.
m
gM.F.  Gacio  et  al.
econd phase of the study
ix  months  after  the  surgery  all  patients  were  contacted
o  start  the  second  phase  of  the  study,  which  aimed  to
etermine  the  presence  of  chronic  pain,  particularly  inter-
ostobrachial  neuralgia,  and  the  quality  of  life  of  these
atients.
From  the  initial  sample  of  80  patients  who  had  partici-
ated  in  the  ﬁrst  phase,  there  was  a  loss  of  14  patients  who
ere  not  included  in  the  second  phase  for  different  reasons:
ollow-up  visits  and  adjuvant  treatments  made  in  other  hos-
itals  that  did  not  allow  coming  to  the  consultation  (four);
efusal  to  participate  in  the  second  phase  (three);  death
one);  patients  undergoing  new  breast  surgery  during  the
ix  months  (six).
The  sample  for  the  second  phase  consisted  of  66  patients:
4  in  the  general  anesthesia  group  and  32  in  the  paraverte-
ral  group.  The  chemotherapy  (CT)  and  radiation  therapy
RT)  received  by  the  patients  were  recorded.
The  66  patients  included  in  the  second  stage  were  invited
o  a  consultation  in  which  a  clinical  interview  was  performed
o  assess  the  presence  of  pain  in  the  area  of  the  operated
reast  and/or  ipsilateral  arm.  To  determine  if  the  pain  had
europathic  characteristics,  the  DN4  scale  was  applied  by
rained  personnel.17 DN4  is  a screening  scale  for  neuropathic
ain,  translated  and  validated  for  the  Portuguese  language
nd  culture,  which  has  a  speciﬁcity  and  sensitivity  of  90%
nd  83%,  respectively.  It  is  a  simple  questionnaire,  easily
pplicable,  consisting  of  four  questions,  two  responded  by
he  patient  and  two  objectively  responded  by  the  clinician.
 total  score  greater  than  four  classiﬁes  pain  as  neuropathic
Fig.  1).
To  assess  these  patients’  quality  of  life,  the  European
rganization  for  Research  and  Treatment  of  Cancer  (EORTC)
cale  was  used.18 It  incorporates  ﬁve  functional  scales,  three
o  assess  symptoms  and  one  each  to  assess  quality  of  life  and
verall  health.  The  score  ranges  from  0  to  100  (0  =  the  worst
ealth  status  and  100  =  the  best  health  status),  except  for
he  symptom  scales  in  which  higher  scores  represent  more
ymptoms  and  worse  quality  of  life.  The  EORTC  QLQ-C30  uses
odules  with  a  nucleus  of  the  generic  questionnaire,  fol-
owed  by  a  combination  of  modules  for  speciﬁc  diseases.  The
ORTC  QLQ-C30  is  followed  by  the  Breast  Speciﬁc  Module
BR-23),  which  evaluates  speciﬁc  aspects  of  breast  cancer
Tables  7  and  8).
econd phase results
egarding  both  groups  comparison  in  the  second  phase,  it
an  be  said  that  demographic  characteristics,  such  as  age
nd  BMI,  are  relatively  homogeneous  and  that  there  were
o  signiﬁcant  differences  between  the  two  groups  regarding
hese  variables.ents  (CT/RT),  which  are  equally  distributed  between  both
roups  (Table  9).
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Questionnaire for neuropathic pain diagnosis: DN4,
Interview of the patient
Examination of the patient
Score
Question 1: Does the pain have one or more of the following characteristics?
Question 2: Is the pain associated with one of more of the following symptoms in the same area?
Question 3: Is the pain located in an area where the physical examination may reveal one or more of the 
following characteristics?
Question 4: In the painful area, can the pain be caused or increased by:
1- Burning
Yes
Yes
No
No
No
2- Painful cold
3- Electric shocks
4- Tingling
5- Pins and needles
6- Numbness
7- Itching
8- Hypoesthesia to touch
10- Brushing
0 – For each negative response  1 – For each positive response
Neuropathic pain: Total score from 4/10.
(    ) Nociceptive pain (    ) Neuropathic pain
Yes
NoYes
9- Hypoesthesia to prick
Please complete this questionnaire by ticking one answer for each number:
Figure  1  Questionnaire  for  neuropathic  pain  
Table  7  EORTC  QLQ-C30.
EORTC  QLQ-C30
General  scale
-  Global  health  status  and  quality  of  life
Functional  scale
- Physical  functioning
-  Role  performance
- Emotional  functioning
- Cognitive  functioning
- Social  functioning
Symptomatic  scale
-  Fatigue
-  Pain
-  Breathlessness
-  Insomnia
-  Lack  of  appetite;  constipation,  diarrhea;
nausea/vomiting
- Financial  difﬁculties
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sdiagnosis:  DN4,  validated  for  Portuguese.
Of  the  66  evaluated  patients,  10  were  diagnosed  with
ain  characteristic  of  intercostobrachial  neuralgia  (seven
n  the  general  anesthesia  group  and  three  in  the  paraver-
ebral  group),  although  the  difference  was  not  signiﬁcant
p  =  0.3).
Regarding  the  EORTC-QLQ  C30  score,  we  found  that
atients  in  the  paravertebral  group  had  the  highest  scores
n  both  overall  quality  of  life  and  in  the  ﬁve  functional
cales,  although  it  was  statistically  signiﬁcant  only  for  social
unction.  In  the  evaluation  of  symptoms,  the  paravertebral
roup  had  lower  values  compared  to  the  general  anes-
hesia  group,  although  it  was  not  statistically  signiﬁcant
Table  10).
Regarding  the  EORTC-BR23  score,  the  paravertebral
roup  showed  better  scores  in  body  image,  with  fewer
ymptoms  compared  to  treatment  side  effects,  as  well  as
ymptoms  in  the  breast  or  arm,  and  we  found  no  statistically
igniﬁcant  differences  (Table  11).
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Table  8  EORTC  QLQ-BR23.
QLQ-BR23
Functional  scale
- Body  image
-  Sexual  functioning
- Sexual  pleasure
- Perspectives
Symptomatic  scale
-  Chemotherapy  effects
- Breast  symptoms
- Arm  symptoms
-  Concern  with  hair  loss
Table  9  Variables  related  to  pain  chronicity  in  the  study
second  phase.
General
anesthesia
Paravertebral + GA P
Age 57 53.22 0.098
Type of surgery 0.2
Mastectomy 11 15
MRM 10 11
Lumpectomy
with axillary
dissection
13 6
BMI 25.755 (3.401) 25.165 (4.0399) 0.5
RT 21 18 0.8
CT 29 25 0.5
Preoperative
breast pain
4 1 0.2
HADS 0.6
<8 51.3% 48.7%
≥8 46.7% 52.3%
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Table  10  Results  of  EORTC  QLQ-C30.
General  anesthesia  (%)
Quality  of  life  60  ±  18.4  
Physical function  80.1  ±  16.7  
Role performance  77  ±  26.2  
Emotional function  69.3  ±  25.4  
Cognitive Function  82.3  ±  20.5  
Social role  82.3  ±  22.8  
Tiredness 30  ±  23.14  
Pain 21  ±  24.3  
Insomnia 30.4  ±  28.8  
Table  11  Results  of  EORTC  QLQ-BR23.
General  anesthesia  (%)  
Body  image  74  ±  23.3  
Perspectives  42.1  ±  36  
Treatment side  effects  25.6  ±  17.1  
Breast symptoms  14.9  ±  16.2  
Arm symptoms  21.2  ±  17.6  M.F.  Gacio  et  al.
iscussion
his  study  intended  to  know  if  with  an  easy  to  perform
echnique,  such  as  paravertebral  block,  and  with  little  dis-
omfort  to  the  patient,  such  as  the  single-injection,  a  good
anagement  of  acute  pain  could  be  achieved  and  if  it  would
elp  to  achieve  a  lower  incidence  of  pain  in  the  intercosto-
rachial  nerve  area  in  the  long  run.
In  the  ﬁrst  phase  of  our  study  it  was  seen  a  decreased
AS  score  in  the  paravertebral  group  for  pain  at  rest  and  on
ovement.  The  duration  of  the  anesthetic  block  at  rest  with
igniﬁcant  scores  only  at  times  0--6  shows  shorter  times  com-
ared  to  other  published  studies.  This  could  be  related  to  the
ower  concentrations  of  adrenaline  used,  which  decrease
he  time-effect  of  the  local  anesthetic.  Although  for  pain  on
ovement,  the  paravertebral  group  had  signiﬁcantly  lower
AS  score  over  24  h.
The  decreased  consumption  of  opioids  both  intraoper-
tively  (fentanyl)  and  postoperatively  (morphine)  in  the
aravertebral  group  demonstrates  the  effectiveness  of  the
ingle-injection  paravertebral  technique  for  postoperative
cute  pain  management  without  serious  complications
nd  improves  comfort  and  hospital  discharge  of
atients.
The  cases  of  PONV  seen  in  both  groups  throughout  the
tudy  were  less  than  expect  based  on  the  type  of  surgery  and
atients’  characteristics.  This  demonstrates  that  the  use  of
 preventive  protocol  allows  reducing  the  onset  of  these
vents  with  the  consequent  comfort  for  patients.
The  second  phase  of  the  study  intended  to  evaluate  the
ncidence  of  intercostobrachial  neuralgia.  The  evaluation
as  performed  six  months  after  surgery  because  radiation
an  worsen  the  painful  symptoms  from  that  moment.
The  diagnosis  was  based  on  clinical  assessment  of
atients  physically  present,  with  the  DN4  scale  application
Paravertebral  (%)  p
63  ±  20  0.52
84.3  ±  13.5  0.36
81.2  ±  22.6  0.55
73.2  ±  19.7  0.63
83.8  ±  16.6  0.99
92.2  ±  14  0.043
20  ±  18  0.12
13.5  ±  20.5  0.2
18.7  ±  23.8  0.8
Paravertebral  +  GA  (%)  p
78.6  ±  23.4  0.4
39.5  ±  36.3  0.8
19.7  ±  17.7  0.15
12  ±  12.1  0.55
17.7  ±  16  0.44
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to  characterize  the  type  of  pain.  We  are  aware  that  this  trav-
eling  to  a  new  consultation  caused  the  loss  of  some  patients
for  the  second  phase.
In  this  study,  we  achieved  homogenization  of  the  inter-
costobrachial  neuralgia  conditioning  characteristics  in  the
sample.  The  studies  by  Tasmuth  et  al.19 report  a  decrease  in
pain  when  the  intercostobrachial  nerve  is  preserved.  Other
studies20 did  not  achieve  the  same  result,  so  the  internal
policy  of  our  surgical  team  remains  the  non-preservation  of
the  intercostobrachial  nerve.
In  the  ﬁrst  phase  of  our  study,  there  was  less  consump-
tion  of  opioids  in  the  GA  and  PVB  groups,  this  is  the  best
indicator  of  better  analgesic  control  and,  according  to  the
meta-analysis  performed  by  Ong  et  al.,  it  is  the  best  indica-
tor  of  the  analgesia  preventive  effects.
However,  the  result  of  our  study  shows  that  there  are
statistically  signiﬁcant  differences  in  the  development  of
intercostobrachial  neuralgia  between  groups.  The  intercos-
tobrachial  nerve  is  a  thoracic  nerve  originating  in  T2.  The
technique  used  in  this  study  was  a  single-injection  at  T4
level.  We  know  that  the  spread  of  solution  with  the  single-
injection  technique  is  erratic,  a  reason  why  groups,  such
as  Greengrass  et  al.,  advocate  the  multiple-injection  tech-
nique  in  surgical  anesthesia.  For  this  reason,  we  believe
that  the  single-injection  paravertebral  block  technique  has  a
patchy  and  poorly  reproducible  distribution  and  conditions
the  local  anesthetic  arrival,  or  not,  at  T2  at  a  sufﬁciently
long  time  to  avoid  a  central  sensitization  that  favors  the
onset  of  postoperative  chronic  pain,  speciﬁcally  intercosto-
brachial  neuralgia.
Because  the  sample  was  calculated  based  on  the  evalua-
tion  of  acute  pain  in  the  immediate  postoperative  period
and  there  were  a  loss  of  patients  for  the  second  phase,
in  addition  to  a  lower  than  expected  incidence  of  chronic
pain,  more  studies  to  assess  chronic  intercostobrachial  neu-
ralgia  after  major  breast  surgery  are  needed  to  evaluate  the
possible  beneﬁts  of  this  technique.
Summary
A  prospective  observational  study  with  a  sample  of  80
patients  stratiﬁed  into  two  groups  of  40  patients  each.  The
groups  were  homogeneous,  with  no  statistically  signiﬁcant
differences  in  age,  type  of  surgery,  HADS,  BMI,  presence  of
breast  pain  before  surgery,  and  family  support  variables.  All
these  are  factors  frequently  reported  as  independent  varia-
bles  for  the  development  of  acute  and/or  chronic  pain.  The
study  aim  was  to  compare  two  different  anesthetic  tech-
niques  for  breast  surgery:  a  single-injection  paravertebral
block  technique  associated  with  general  anesthesia  versus
general  anesthesia  technique  alone.  The  study  was  per-
formed  over  24  h  in  the  immediate  postoperative  period  and
a  second  evaluation  six  months  after  surgery.  The  single-
injection  paravertebral  block  allows  adequate  control  of
acute  pain  with  less  intraoperative  and  postoperative  con-
sumption  of  opioids  in  the  ﬁrst  24  h,  but  apparently  it  cannot
prevent  pain  chronicity,  particularly  intercostobrachial  neu-
ralgia.  More  studies  are  needed  to  establish  the  beneﬁcial
effects  of  paravertebral  block  in  pain  chronicity  in  major
breast  surgery.
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